• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命终末期的姑息治疗和症状负担:一项基于人群的胃肠道癌症患者研究。

Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer.

机构信息

Department of Surgery, Queen's University, Kingston, ON, Canada.

Division of General Surgery and Surgical Oncology, Kingston Health Sciences Centre, Kingston, ON, Canada.

出版信息

Ann Surg Oncol. 2019 Aug;26(8):2336-2345. doi: 10.1245/s10434-019-07320-z. Epub 2019 Apr 9.

DOI:10.1245/s10434-019-07320-z
PMID:30969388
Abstract

INTRODUCTION

The symptom profile in cancer patients and the association between palliative care (PC) and symptoms has not been studied in the general population. We addressed these gaps in gastrointestinal (GI) cancer patients in the final year of life.

METHODS

Patients dying of esophageal, gastric, colon, and anorectal cancers during 2003-2015 were identified. Symptom scores were recorded in the year before death using the Edmonton Symptom Assessment System (ESAS), which includes scores from 0 to 10 in nine domains. Symptom severity was categorized as none-mild (≤ 3) or moderate-severe (≥ 4-10). Adjusted associations between outpatient PC and moderate-severe ESAS scores were determined, and the effect of PC initiation on ESAS scores was estimated.

RESULTS

The cohort included 11,242 patients who died (esophageal [17%], gastric [20%], colon [38%], and anorectal [26%] cancers). Fifty percent experienced moderate-severe scores in tiredness, lack of well-being, and lack of appetite earlier (weeks 18 to 12 before death), whereas 50% experienced moderate-severe scores in drowsiness, pain, and shortness of breath later (weeks 5 to 2 before death) in the disease course. Outpatient PC was associated with an increased likelihood of moderate-severe scores in all domains, with the highest score in pain (odds ratio [OR] 1.86, 95% confidence interval [CI] 1.68-2.05). In PC-naïve patients with moderate-severe scores, initiation of outpatient PC was associated with a 1- to 3-point decrease in subsequent scores, with the greatest reductions in pain (OR - 1.91, 95% CI - 2.11 to - 1.70) and nausea (OR - 3.01, 95% CI - 3.31 to - 2.71).

CONCLUSION

GI cancer patients experience high symptom burden in the final year of life. Outpatient PC initiation is associated with a decrease in symptoms.

摘要

简介

在普通人群中,尚未研究癌症患者的症状特征以及姑息治疗(PC)与症状之间的关联。我们针对终末期胃肠道(GI)癌症患者填补了这一空白。

方法

确定了 2003 年至 2015 年间死于食管、胃、结肠和直肠肛门癌的患者。在死亡前一年使用埃德蒙顿症状评估系统(ESAS)记录症状评分,该系统包括 0 至 10 分的 9 个领域的评分。症状严重程度分为无-轻度(≤3)或中度-重度(≥4-10)。确定了门诊 PC 与中度-重度 ESAS 评分之间的调整关联,并估计了 PC 开始对 ESAS 评分的影响。

结果

该队列包括 11242 名死亡患者(食管癌[17%]、胃癌[20%]、结肠癌[38%]和直肠癌[26%])。50%的患者在疾病过程中更早(死亡前 18 至 12 周)出现疲劳、不适和食欲不振的中度-重度评分,而 50%的患者在较晚(死亡前 5 至 2 周)出现嗜睡、疼痛和呼吸急促的中度-重度评分。门诊 PC 与所有领域的中度-重度评分的可能性增加相关,疼痛的评分最高(比值比[OR] 1.86,95%置信区间[CI] 1.68-2.05)。在有中度-重度评分且无门诊 PC 经验的患者中,门诊 PC 的启动与随后评分的 1 至 3 分下降相关,在疼痛(OR-1.91,95%CI-2.11 至-1.70)和恶心(OR-3.01,95%CI-3.31 至-2.71)方面的降幅最大。

结论

GI 癌症患者在生命的最后一年中经历了高症状负担。门诊 PC 的启动与症状的减轻有关。

相似文献

1
Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer.生命终末期的姑息治疗和症状负担:一项基于人群的胃肠道癌症患者研究。
Ann Surg Oncol. 2019 Aug;26(8):2336-2345. doi: 10.1245/s10434-019-07320-z. Epub 2019 Apr 9.
2
Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.接受姑息化疗的食管癌和胃癌患者的症状演变:一项基于人群的研究。
Ann Surg Oncol. 2021 Jan;28(1):79-87. doi: 10.1245/s10434-020-09289-6. Epub 2020 Nov 2.
3
Performance status and symptom scores of women with gynecologic cancer at the end of life.妇科癌症患者生命终末期的体能状态和症状评分。
Int J Gynecol Cancer. 2013 Jun;23(5):971-8. doi: 10.1097/IGC.0b013e318291e5ef.
4
Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.神经内分泌肿瘤患者生命终末期的症状负担:对 2579 份前瞻性采集的患者报告结局的分析。
Ann Surg Oncol. 2019 Sep;26(9):2711-2721. doi: 10.1245/s10434-019-07441-5. Epub 2019 May 30.
5
Patient-Reported Symptom Severity Among 22,650 Cancer Outpatients in the Last Six Months of Life.22650 例癌症晚期门诊患者报告的症状严重程度。
J Pain Symptom Manage. 2020 Jan;59(1):58-66.e4. doi: 10.1016/j.jpainsymman.2019.08.016. Epub 2019 Aug 17.
6
The Optimal Cutoff Point for Expressing Revised Edmonton Symptom Assessment System Scores as Binary Data Indicating the Presence or Absence of Symptoms.将修订后的埃德蒙顿症状评估系统评分表示为表明症状存在或不存在的二元数据时的最佳截断点。
Am J Hosp Palliat Care. 2018 Nov;35(11):1390-1393. doi: 10.1177/1049909118775660. Epub 2018 May 7.
7
Edmonton symptom assessment scale: Italian validation in two palliative care settings.埃德蒙顿症状评估量表:在两种姑息治疗环境中的意大利语验证
Support Care Cancer. 2006 Jan;14(1):30-7. doi: 10.1007/s00520-005-0834-3. Epub 2005 Jun 4.
8
Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.约旦一家三级癌症中心门诊姑息治疗对晚期癌症患者症状负担的影响。
Support Care Cancer. 2017 Jan;25(1):177-183. doi: 10.1007/s00520-016-3395-8. Epub 2016 Sep 7.
9
A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients.一项多中心研究比较了两种数字版埃德蒙顿症状评估系统在姑息治疗患者中的应用。
J Pain Symptom Manage. 2011 Feb;41(2):456-68. doi: 10.1016/j.jpainsymman.2010.04.020. Epub 2010 Sep 15.
10
Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.使用埃德蒙顿症状评估系统评估晚期癌症患者呼吸困难的症状相关性。
Support Care Cancer. 2020 Jan;28(1):87-98. doi: 10.1007/s00520-019-04787-0. Epub 2019 Apr 13.

引用本文的文献

1
Symptom prevalence in gastrointestinal cancer: a secondary analysis of IPOS data.胃肠道癌症的症状患病率:IPOS数据的二次分析
Support Care Cancer. 2025 Sep 18;33(10):860. doi: 10.1007/s00520-025-09919-3.
2
Reverse Time-to-Death as Time-Scale in Time-to-Event Analysis for Studies of Advanced Illness and Palliative Care.在晚期疾病和姑息治疗研究的事件发生时间分析中,将反向死亡时间用作时间尺度。
Stat Med. 2025 Feb 10;44(3-4):e10338. doi: 10.1002/sim.10338.
3
Threats to the Dignity of People with Advanced Illness Who Are Treated in Emergency Departments: A Qualitative Study.
急诊科中晚期疾病患者尊严受到的威胁:一项定性研究。
Healthcare (Basel). 2024 Dec 22;12(24):2581. doi: 10.3390/healthcare12242581.
4
Aggressive end-of-life care in patients with gastrointestinal cancers - a nationwide study from Denmark.胃肠道癌症患者的积极临终关怀 - 来自丹麦的全国性研究。
Acta Oncol. 2024 Nov 24;63:915-923. doi: 10.2340/1651-226X.2024.41008.
5
Exploring the Influence of the Edmonton Symptom Assessment System Implementation in Palliative Care Patients: A Systematic Review.探索埃德蒙顿症状评估系统在姑息治疗患者中的实施效果:一项系统综述。
Cureus. 2024 Oct 6;16(10):e70914. doi: 10.7759/cureus.70914. eCollection 2024 Oct.
6
Palliative care case management in a surgical department for patients with gastrointestinal cancer-a register-based cohort study.外科部门中针对胃肠道癌症患者的姑息治疗病例管理:基于注册的队列研究。
Support Care Cancer. 2024 Aug 16;32(9):592. doi: 10.1007/s00520-024-08794-8.
7
Patterns of acute hospital and specialist palliative care use among people with non-curative upper gastrointestinal cancer.非根治性上消化道癌症患者的急性医院和专科姑息治疗使用模式。
Support Care Cancer. 2024 Jun 14;32(7):432. doi: 10.1007/s00520-024-08624-x.
8
Associations between health-related quality of life and subsequent need for specialized palliative care and hospital utilization in patients with gastrointestinal cancer-a prospective single-center cohort study.胃肠道癌症患者健康相关生活质量与后续对专科姑息治疗和医院利用需求的相关性:一项前瞻性单中心队列研究。
Support Care Cancer. 2024 Apr 27;32(5):311. doi: 10.1007/s00520-024-08509-z.
9
Care Delivery Interventions for Individuals with Cancer: A Literature Review and Focus on Gastrointestinal Malignancies.针对癌症患者的护理干预措施:文献综述及对胃肠道恶性肿瘤的关注
Healthcare (Basel). 2023 Dec 22;12(1):30. doi: 10.3390/healthcare12010030.
10
The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer.自然语言处理在评估晚期癌症患者社会支持中的应用。
Oncologist. 2023 Feb 8;28(2):165-171. doi: 10.1093/oncolo/oyac238.